increased intestinal adenoma incidence_Apc<Min>/Apc<+>,Glp2r<tm1Ddr>/Glp2r<+>

http://metadb.riken.jp/0002404IC57BL6JApcMinApcGlp2rtm1DdrGlp2rGlp2rtm1DdrApcMinGlp2rApc

increased intestinal adenoma incidence_Apc<Min>/Apc<+>,Glp2r<tm1Ddr>/Glp2r<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• adenomatosis polyposis coli
  http://metadb.riken.jp/db/mgi_rdf/MGI:88039
• glucagon-like peptide 2 receptor
  http://metadb.riken.jp/db/mgi_rdf/MGI:2136733

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apc<Min>/Apc<+>,Glp2r<tm1Ddr>/Glp2r<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Glp2r<tm1Ddr>|Apc<Min>|Glp2r<+>|Apc<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased intestinal adenoma incidence
  http://purl.obolibrary.org/obo/MP_0002404

文献

http://purl.org/net/cito/citesAsAuthority

• Jacqueline A. Koehler, et.al., Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells., Cancer research, 2008, 68
  http://rdf.ncbi.nlm.nih.gov/pubmed/18829546